Ryota Morimoto

1.7k total citations
120 papers, 963 citations indexed

About

Ryota Morimoto is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering. According to data from OpenAlex, Ryota Morimoto has authored 120 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Cardiology and Cardiovascular Medicine, 32 papers in Surgery and 22 papers in Biomedical Engineering. Recurrent topics in Ryota Morimoto's work include Cardiovascular Function and Risk Factors (22 papers), Mechanical Circulatory Support Devices (18 papers) and Cardiac Structural Anomalies and Repair (17 papers). Ryota Morimoto is often cited by papers focused on Cardiovascular Function and Risk Factors (22 papers), Mechanical Circulatory Support Devices (18 papers) and Cardiac Structural Anomalies and Repair (17 papers). Ryota Morimoto collaborates with scholars based in Japan, United States and United Kingdom. Ryota Morimoto's co-authors include Toyoaki Murohara, Takahiro Okumura, Toru Kondo, Hiroaki Hiraiwa, Hideki Ishii, Tasuku Kuwayama, Akinori Sawamura, Yoshinari Yasuda, Yosuke Tatami and Susumu Suzuki and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ryota Morimoto

101 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryota Morimoto Japan 17 350 236 143 138 122 120 963
Mehdi Rasouli Iran 20 186 0.5× 193 0.8× 168 1.2× 95 0.7× 128 1.0× 41 919
Xue Tian China 16 212 0.6× 98 0.4× 169 1.2× 128 0.9× 117 1.0× 83 904
Claudine Cosson France 19 271 0.8× 289 1.2× 196 1.4× 115 0.8× 58 0.5× 46 978
A Barsotti Italy 15 491 1.4× 240 1.0× 164 1.1× 141 1.0× 148 1.2× 59 1.2k
Yin Zhang China 16 234 0.7× 171 0.7× 209 1.5× 98 0.7× 65 0.5× 88 958
Dae Hyun Lee United States 14 233 0.7× 147 0.6× 193 1.3× 92 0.7× 112 0.9× 53 947
Burak Pamukçu Türkiye 21 682 1.9× 213 0.9× 230 1.6× 127 0.9× 119 1.0× 45 1.4k
Lorenzo Franceschini Italy 22 796 2.3× 161 0.7× 449 3.1× 133 1.0× 94 0.8× 46 1.5k
Markus Wallner Austria 17 481 1.4× 184 0.8× 355 2.5× 65 0.5× 82 0.7× 61 965
Taka‐aki Matsuyama Japan 19 537 1.5× 319 1.4× 257 1.8× 104 0.8× 120 1.0× 86 1.2k

Countries citing papers authored by Ryota Morimoto

Since Specialization
Citations

This map shows the geographic impact of Ryota Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Morimoto more than expected).

Fields of papers citing papers by Ryota Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Morimoto. The network helps show where Ryota Morimoto may publish in the future.

Co-authorship network of co-authors of Ryota Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Morimoto. A scholar is included among the top collaborators of Ryota Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Morimoto. Ryota Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morimoto, Ryota, S. Kazama, Hiroaki Hiraiwa, et al.. (2025). Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated With Trastuzumab and Pertuzumab. Circulation Reports. 7(9). 800–808. 1 indexed citations
2.
Kondo, Toru, Ryota Morimoto, S. Kazama, et al.. (2025). Direct Visualization of External Outflow Graft Obstruction in Durable Left Ventricular Assist Device Using Transthoracic Echocardiography. ASAIO Journal. 71(12). e231–e234. 1 indexed citations
3.
Hiraiwa, Hiroaki, Ryota Ito, S. Kazama, et al.. (2025). Ability of dynamic chest radiography to identify left ventricular systolic dysfunction in heart failure. The International Journal of Cardiovascular Imaging. 41(3). 507–521.
4.
5.
Kondo, Toru, Tomo Yoshizumi, Ryota Morimoto, et al.. (2024). Predicting Survival After Impella Implantation in Patients with Cardiogenic Shock: The J-PVAD Risk Score. European Journal of Heart Failure. 27(1). 51–59. 5 indexed citations
6.
Hiraiwa, Hiroaki, Ryota Ito, Yuichiro Koyama, et al.. (2024). Usefulness of bicarbonate-based Impella purge solution in a patient with heparin-induced thrombocytopenia: the first case report of long-term management in Japan. Journal of Artificial Organs. 28(1). 83–89.
7.
Kuranaga, Takefumi, et al.. (2024). Twisted Amide‐Mediated Peptide Synthesis. Chemistry - A European Journal. 30(65). e202403288–e202403288. 3 indexed citations
8.
Shimizu, Miho, Hiroaki Hiraiwa, Shinya Tanaka, et al.. (2023). Cardiac Rehabilitation in Severe Heart Failure Patients with Impella 5.0 Support via the Subclavian Artery Approach Prior to Left Ventricular Assist Device Implantation. Journal of Personalized Medicine. 13(4). 630–630. 3 indexed citations
9.
Jacobson, M. E., R. Seshadri, Ryota Morimoto, et al.. (2023). Early intervention and disease modification in atopic dermatitis—the current state of the field and barriers to progress. Journal of the European Academy of Dermatology and Venereology. 38(4). 665–672. 4 indexed citations
10.
Hiraiwa, Hiroaki, Ryota Morimoto, Ryota Ando, et al.. (2022). Recurrent fulminant non-rheumatic streptococcal myocarditis proven by endomyocardial biopsy and autopsy. Journal of Cardiology Cases. 26(1). 62–65. 9 indexed citations
11.
Kazama, S., Toru Kondo, Naoki Shibata, et al.. (2021). Clinical Impact of Heart Rate Change in Patients with Acute Heart Failure in the Early Phase. ESC Heart Failure. 8(4). 2982–2990. 1 indexed citations
12.
Okumura, Takahiro, Hiroaki Hiraiwa, Takashi Araki, et al.. (2020). Two cases of dilated cardiomyopathy with blood pressure-limited tolerability of cardioprotective agents improved by ivabradine. Journal of Cardiology Cases. 23(4). 149–153. 2 indexed citations
13.
14.
Yamaguchi, Shogo, Akinori Sawamura, Masato Nakaguro, et al.. (2019). Giant cell myocarditis with central diabetes insipidus: A case report. Journal of Cardiology Cases. 21(1). 8–11. 3 indexed citations
15.
Hiraiwa, Hiroaki, Ryota Morimoto, Takahiro Okumura, et al.. (2019). A survival case of a young adult patient with ST-elevated myocardial infarction with high levels of lipoprotein(a). Journal of Cardiology Cases. 19(6). 207–210. 1 indexed citations
16.
Morimoto, Ryota, Kei Kohno, Akinori Sawamura, et al.. (2018). 免疫チェックポイント阻害剤ニボルマブによる遅発性劇症心筋炎【JST・京大機械翻訳】. Canadian Journal of Cardiology. 34(6). 1–812. 1 indexed citations
17.
Kondo, Toru, Ryota Morimoto, Tsuyoshi Yokoi, et al.. (2018). Hemodynamics of cardiac tamponade during extracorporeal membrane oxygenation support in a patient with fulminant myocarditis. Journal of Cardiology Cases. 19(1). 22–24. 12 indexed citations
18.
19.
Hiraiwa, Hiroaki, Takahiro Okumura, Akinori Sawamura, et al.. (2017). The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy. Journal of Cardiology. 71(3). 284–290. 14 indexed citations
20.
Kondo, Keita, et al.. (2009). Sirolimus-eluting stent implantation for ostial stenosis of left main coronary artery after Bentall operation in aortitis syndrome. Journal of Cardiology. 55(1). 147–150. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehdi Rasouli Breakdown of academic impact, for papers by Xue Tian Breakdown of academic impact, for papers by Claudine Cosson Breakdown of academic impact, for papers by A Barsotti Breakdown of academic impact, for papers by Yin Zhang Breakdown of academic impact, for papers by Dae Hyun Lee Breakdown of academic impact, for papers by Burak Pamukçu Breakdown of academic impact, for papers by Lorenzo Franceschini Breakdown of academic impact, for papers by Markus Wallner Breakdown of academic impact, for papers by Taka‐aki Matsuyama
Rankless by CCL
2026